Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

← Obstetrics and gynaecology indexChapter sections
OverviewAetiologyPathophysiologyClinical features and red flagsInvestigationsDifferential diagnosisManagementComplicationsMonitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook13 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Placenta praevia

Obstetrics and gynaecology · UK scope · Sources checked 7 Sept 2026 · Clinical review pending

RapidFull
!
Bleeding with possible placenta praevia

Fresh bleeding can progress rapidly even when the uterus is soft and the patient initially appears well.

Action: Call the maternity emergency team, assess circulation and fetal wellbeing, secure intravenous access and blood samples, and avoid digital vaginal examination until praevia has been excluded.

Overview

Recognise bleeding from a low placental implantation, establish its relation to the cervix safely, and plan surveillance and birth around maternal haemorrhage risk.

Placental position matters because the cervix and lower uterine segment must remodel before vaginal birth. Placenta praevia lies at or across the internal os, whereas a low-lying placenta ends less than 20 mm from it without reaching the os. Record the measured distance and whether tissue actually reaches the os instead of using older grades such as marginal or major. At the mid-pregnancy scan a low placenta is a provisional anatomical finding: uterine growth often increases the edge-to-os distance later. Persistent low implantation in the third trimester carries a different risk from a resolved second-trimester finding.

Bleeding commonly occurs when stretching of the lower segment disrupts maternal vessels at the placental attachment. The classical presentation is painless, fresh vaginal loss with a non-tender uterus. However, labour, abruption and other pathology can coexist, and symptom labels must never delay resuscitation. Severity is assessed from maternal circulation, ongoing loss and fetal condition, not colour or the apparent volume on a pad. An initially normal haemoglobin reflects the timing of blood sampling and cannot rule out important acute blood loss.

Aetiology

01

Altered implantation environment

Previous caesarean birth and other uterine procedures can alter the endometrial surface, increasing the chance that placentation develops in the lower uterine segment.

02

Associated reproductive factors

Assisted conception, smoking and previous low placentation are recognised associations; risk factors guide surveillance but their absence cannot exclude a low placenta.

Pathophysiology

  1. 1
    Lower-segment attachment

    Placental tissue remains close to the cervical opening as the uterus enlarges, leaving its attachment exposed to stretching during late pregnancy and labour.

  2. 2
    Maternal vessel disruption

    Separation at the placental edge opens maternal vessels, producing external bleeding that may recur whenever further cervical or lower-segment change occurs.

  3. 3
    Impaired postnatal contraction

    The lower uterine segment contracts less effectively around the placental bed, so persistent implantation there can increase bleeding after placental separation at birth.

Clinical features and red flags

Typical haemorrhage

Fresh bleeding after mid-pregnancy may stop spontaneously and then recur; ask about every episode and assess the current circulation.

Abnormal presentation

A high presenting part, breech or transverse lie can accompany low placentation but cannot establish the diagnosis without imaging.

Combined scar risk

An anterior low placenta over a previous caesarean scar should prompt specific assessment for abnormal placental attachment before an operative plan is agreed.

Changing clinical course

Pain, uterine activity, fluid loss or reduced fetal movement needs immediate reassessment even if earlier bleeding was small and painless.

Red flags requiring action

  • Heavy bleeding, syncope, tachycardia or hypotension requires immediate obstetric haemorrhage resuscitation and senior review.
  • New pain, contractions, membrane rupture or abnormal fetal heart rate may indicate imminent birth or a second placental emergency.

Investigations

  1. 01
    First assessment of maternal physiologyFirst step
    Why
    Detect haemorrhagic compromise and guide urgency before detailed placental imaging.
    Interpretation and limitations
    Record pulse, blood pressure, respiratory rate, oxygen saturation, temperature, mental state and loss; compensated circulation may deteriorate abruptly.
  2. 02
    Transvaginal placental localisation
    Why
    Measure the leading placental edge relative to the internal cervical os.
    Interpretation and limitations
    A trained operator can scan safely; transvaginal imaging is not equivalent to a digital examination that might disturb placental tissue.
  3. 03
    Full blood count, group and antibody screen
    Why
    Identify anaemia, RhD status and transfusion complexity in the bleeding patient.
    Interpretation and limitations
    Request crossmatched blood for significant loss and add coagulation studies including fibrinogen when bleeding is substantial or continuing.
  4. 04
    Fetal heart assessment and ultrasound
    Why
    Assess fetal condition, presentation, growth and associated placental abnormalities.
    Interpretation and limitations
    Use gestation-appropriate monitoring; a reassuring trace does not remove maternal haemorrhage risk and an abnormal trace may accelerate birth.
  5. 05

Differential diagnosis

01

Placental abruption

Pain, uterine tenderness or sustained tone may indicate placental separation, but concealed bleeding and overlapping symptoms mean coexistence must remain possible.

02

Cervical or vaginal bleeding

Ectropion, polyps, infection or trauma can produce visible blood; careful assessment is needed before assigning a benign source in later pregnancy.

03

Vasa praevia

Bleeding after membrane rupture with rapid fetal deterioration suggests torn fetal vessels, where a seemingly modest loss can be catastrophic for the fetus.

Management

01EmergencyStabilise active significant bleedingFirst stepBleeding is ongoing, circulation is abnormal or fetal compromise is suspected.+
  1. 1Activate the obstetric haemorrhage response, obtain large-bore intravenous access, send urgent bloods and coordinate blood-product availability with the laboratory.
  2. 2Assess maternal and fetal status in parallel; avoid digital cervical examination and arrange urgent delivery when haemorrhage or compromise makes continued pregnancy unsafe.
  3. 3Involve consultant obstetrics, anaesthesia and neonatal staff early, explaining the possible need for transfusion, caesarean birth and haemorrhage-control procedures.
02Antenatal careManage stable persistent low placentationUltrasound confirms low placentation and there is no immediate delivery indication.+
  1. 1Record placental position, symptom history, haemoglobin, previous uterine surgery and travel circumstances, then agree hospital or outpatient care individually.

Complications

01

Major maternal haemorrhage

Recurrent or sudden severe loss may cause shock, transfusion requirement and emergency surgery, with hysterectomy occasionally needed when bleeding cannot otherwise be controlled.

02

Preterm birth

Bleeding or labour may require delivery before fetal maturity, exposing the infant to respiratory, feeding, temperature-control and other gestation-related difficulties.

03

Persistent postpartum bleeding

Poor lower-segment contraction and associated abnormal attachment can complicate placental delivery, increasing the need for uterotonics, tamponade or operative haemorrhage control.

Monitoring and follow-up

  • Reassess pulse, pressure, symptoms and observed loss after each bleed; make frequency proportional to ongoing risk rather than relying on a single stable observation set.
  • Trend haemoglobin and iron status during conservative care, and confirm that prescribed replacement has improved anaemia before planned surgery.
  • For continuing recurrent bleeding after 20 weeks, coordinate anti-D at least every six weeks and fetomaternal-haemorrhage testing at least every two weeks with transfusion services; a changed or new event needs fresh assessment.
  • Document the latest placental map, agreed birth date, emergency plan and contact details in a record accessible to both the admitting unit and community team.
  • After birth, monitor for postpartum haemorrhage and anaemia, and offer a debrief about emergency interventions or separation from a preterm infant.

Special situations

A scan is safer than a finger

The probe remains in the vagina while imaging the cervix; it does not traverse the cervical canal or intentionally disturb the placental edge.

Timing guidance has changed

The 2026 RCOG recommendation for asymptomatic uncomplicated praevia should replace automatic use of the older 36–37-week schedule; symptoms still justify earlier intervention.

Low-lying does not mean invasive

Position and attachment are distinct questions, although previous caesarean scarring makes the combination sufficiently important to require expert imaging.

Avoid universal activity prescriptions

Explain the individual bleeding plan and practical access to care; prolonged routine bed rest has burdens and does not substitute for haemorrhage preparedness.

Common pitfalls

  1. 01

    Performing a digital vaginal examination before excluding placenta praevia in a patient with unexplained antepartum bleeding.

  2. 02

    Discharging after a small recurrent bleed without considering anaemia, distance from hospital and the patient's ability to return urgently.

  3. 03

    Treating a normal acute haemoglobin concentration as proof that substantial haemorrhage has not occurred.

  4. 04

    Using the earlier 2018 delivery window automatically after a new 2026 national recommendation has altered the uncomplicated pathway.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
Obstetrics and gynaecologyOriginal SBA

Safely defining placental position

A patient at 31 weeks has a small painless bleed and stable observations. A transabdominal scan cannot define the placental edge relative to the cervix. Which assessment best clarifies this uncertainty?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Obstetrics and gynaecology topics →
Sources and review status5 sources · checked 7 Sept 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.

  • RCOG Green-top 27a placenta praevia and accreta spectrum, 2026
  • RCOG Green-top 63 antepartum haemorrhage
  • BSH anti-D immunoglobulin prophylaxis guidance
  • NICE NG25 preterm labour and birth
  • RCOG Green-top 74 antenatal corticosteroid regimens

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
Planning separates the stable patient from the patient with active bleeding. Outpatient care may suit an asymptomatic person with reliable transport, support and ready access to hospital. Recurrent bleeding, anaemia, pain, contractions or difficult access favours admission or more intensive surveillance. RCOG's June 2026 revision recommends individualised timing with planned birth no later than 37+6 weeks for uncomplicated low-lying placenta or praevia, and identifies 37+0–37+6 as the planned window for asymptomatic praevia without additional risks. Earlier birth is justified by symptoms or deterioration; completing steroid treatment must not defer necessary delivery.

Key points

  • Placenta praevia reaches or covers the internal cervical os; a low-lying placenta has an edge less than 20 mm away without covering it.
  • Painless bright bleeding is characteristic, but pain does not exclude praevia or concurrent abruption.
  • Transvaginal ultrasound by an experienced operator safely defines the placental edge and is more accurate than a limited transabdominal view.
  • A placenta reported low at the anomaly scan usually needs reassessment at 32 weeks, with further imaging determined by persistence and birth planning.
  • Previous caesarean birth with anterior low placentation raises concern for placenta accreta spectrum and requires targeted expert assessment.
  • RCOG 2026 supports planned birth by 37+6 weeks for uncomplicated low placentation; asymptomatic praevia without other risk factors is generally planned at 37+0–37+6.
  • For a non-sensitised RhD-negative patient with bleeding after 20 weeks, give at least 500 IU anti-D within 72 hours and quantify fetomaternal haemorrhage.
Fetomaternal haemorrhage quantification
Why
Calculate additional anti-D requirements after a sensitising bleed from 20 weeks.
Interpretation and limitations
Send the laboratory sample promptly but do not wait for its result before the initial indicated prophylactic dose.
  • 2Arrange localisation around 32 weeks after a low anomaly-scan result; if low lying or praevia persists, reassess transvaginally around 36 weeks to guide birth planning.
  • 3Provide a direct maternity contact and explicit return advice for any bleeding, contractions, pain or membrane rupture; treat identified iron deficiency and review transfusion preferences.
  • 03Birth planningMatch delivery arrangements to anatomy and symptomsPlacental findings persist into the third trimester or recurrent symptoms alter risk.+
    1. 1Plan caesarean birth for persistent praevia in a unit with on-site blood transfusion and critical-care access; screen suspected accreta through the specialist pathway.
    2. 2Discuss a trial of labour for an asymptomatic low-lying placenta with an edge-to-os distance of 11–20 mm after 36 weeks, alongside the clinical course, preferences and experienced team’s assessment; the measurement does not guarantee vaginal birth.
    3. 3For asymptomatic uncomplicated praevia discuss the 37+0–37+6-week window; bring birth forward for bleeding, labour, fetal concerns or other maternal indications.
    Key medicines and prescribing safety2 treatments · regimens, roles and cautions+
    Prevents RhD sensitisation following a potentially sensitising maternal bleeding event.

    Anti-D immunoglobulin after antepartum bleeding

    For non-sensitised RhD-negative patients after 20 weeks, administer at least 500 IU within 72 hours, intramuscularly or intravenously according to the licensed preparation; give extra doses according to quantified fetomaternal haemorrhage.

    Routine antenatal prophylaxis does not replace event-related treatment. Confirm product route, previous immune anti-D and laboratory advice for recurrent or large haemorrhage.

    Reduces complications of prematurity when the expected timing of birth makes treatment beneficial.

    Antenatal betamethasone when preterm birth is likely

    For the betamethasone sodium phosphate/acetate mixture, give 12 mg intramuscularly twice, 24 hours apart. UK phosphate-only preparations differ; confirm the unit’s formulation-specific course when preterm birth is anticipated.

    Select eligibility using current obstetric guidance, increase glucose surveillance with diabetes, and never postpone urgently indicated birth to complete the course.